Myungmun Pitavastatin Tablet 4mg (Pitavastatin Calcium)

Adult dose

For adults, the usual initial dose of pitavastatin calcium is 1 to 2 milligrams once daily. If the effect of lowering LDL cholesterol is not sufficient, the dose can be increased to a maximum of 4 milligrams per day. The dosage should be adjusted appropriately at intervals of 4 weeks or more based on LDL cholesterol levels, therapeutic targets, and patient response.

This medication should not be used in patients allergic to specific components. Patients with active liver disease or those with persistently elevated liver enzyme test results should not take this drug. It should not be administered to patients with severe liver impairment or obstructive biliary diseases. Patients taking cyclosporine should not use this drug. It should also not be taken by patients with myopathy. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not use this medication. The safety and efficacy in children have not been established, thus it is not used. Patients with lactose intolerance or specific genetic metabolic disorders should also avoid this drug. Patients with impaired renal function or a history of liver disease should use this medication cautiously, especially when taken with specific lipid-lowering agents, as there may be an increased risk of muscle damage. Patients who consume large amounts of alcohol should be careful when using this medication. Elderly patients, those with hypothyroidism, and patients with myopathies or a family history of such conditions should also be cautious. This drug may cause various side effects including muscle pain, muscle weakness, liver function abnormalities, and allergic reactions, so any unusual symptoms should be discussed with a medical professional immediately. If muscle pain or weakness intensifies, this medication should be discontinued immediately due to the risk of muscle damage. Regular liver function tests should be conducted, and if liver enzyme levels increase, the medication should be discontinued. This drug can interact with other medications, so inform your healthcare provider about any other medications you are taking. Taking this drug along with cyclosporine, certain lipid-lowering agents, or niacin may increase the risk of kidney function deterioration and muscle damage, so co-administration should be avoided or carefully monitored. Before administration, dietary therapy and exercise therapy should be adequately conducted, and blood lipid levels should be regularly tested; if there is no therapeutic effect, the medication should be discontinued. This medication should not be split and should be swallowed whole, and it should be kept out of reach of children. Pregnant or breastfeeding women should not take this medication, and it should be discontinued if pregnancy is confirmed. Elderly patients may have decreased physical function, increasing the likelihood of side effects, so dosage adjustment and caution are necessary. This drug is not used in children as its safety and efficacy have not been established.

Serious side effects

• Hives
• severe swelling (edema)
• liver dysfunction
• jaundice
• decreased platelets
• rhabdomyolysis
• sudden and severe headache
• paralysis
• visual disturbances
• worsened kidney function

Mild side effects

• Abdominal pain
• rash
• fatigue
• paralysis
• itching
• stiffness
• drowsiness
• insomnia
• headache
• heaviness in the head

This medication may be sensitive to light, so it should be stored in an opaque container. Additionally, it is best to store the drug at room temperature, specifically between 1 degree and 30 degrees Celsius. Storing it this way maintains the drug's efficacy and safety.

Appearance

Yellow round film-coated tablet with a score line

Package unit

30 tablets/bottle, 100 tablets/bottle